Summary
The immunochemical analysis of enzyme from mucopolysaccharidoses (MPS) patients is aimed at defining the level and nature of the enzymically deficient protein produced by specific gene mutations. Immunochemical techniques allow purification of enzyme, characterization of the composite molecular species, measurement of cellular protein content, investigation of protein biosynthesis, determination of subcellular distribution, as well as information on protein structure and folding. This review focuses on the application of immunochemical techniques to the study of the aberrant protein produced in skin fibroblast cells derived from MPS patients. The analysis of enzyme protein has been applied to phenotype expression within single enzyme deficiency disorders. It is proposed that reliable prediction of MPS patient phenotype may require a combined approach utilizing immunochemical, biochemical, cell biological and gene analysis. However, this review will address the structure and nature of the protein produced in cells from MPS patients, the biological activity of this protein, and the incorporation of the protein into, and location within, subcellular fractions.
Similar content being viewed by others
References
Ashton LJ, Brooks DA, McCourt PAG, Muller VJ, Clements PR, Hopwood JJ (1992) Immunoquantification and enzyme kinetics of α-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.Am J Hum Genet 50: 787–794.
Bell CE, Sly WS, Brot FE (1977) Human β-glucuronidase deficiency mucopolysaccharidosis. Identification of cross-reactive antigen in cultured fibroblasts of deficient patients by immunoassay.J Clin Invest 59: 97–105.
Brooks DA, McCourt PAG, Gibson GJ, Hopwood JJ (1990) Immunoquantification of the low abundance lysosomal enzymeN-acetylgalactosamine 4-sulphatase.J Inher Metab Dis 13: 108–120.
Brooks DA, Gibson GJ, McCourt PAG, Hopwood JJ (1991a) A specific fluorogenic assay forN-acetylgalactosamine-4-sulphatase activity using immunoadsorption.J Inher Metab Dis 14: 5–12.
Brooks DA, McCourt PAG, Gibson GJ, Ashton LJ, Shutter M, Hopwood JJ (1991b) Analysis ofN-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients.Am J Hum Genet 48: 710–719.
Brooks DA, Harper GS, Gibson GJ et al (1992) Hurler syndrome: a patient with abnormally high levels of α-l-iduronidase protein.J Biochem Med Metab Biol 47: 211–220.
Butler JE, Peterman JH, Suter M, Dierks SE (1987) The immunochemistry of solid-phase sandwich enzyme-linked immunosorbent assays.Fedn Proc 46: 2548–2556.
Clements PR, Brooks DA, Saccone GTP, Hopwood JJ (1985) Human α-L-iduronidase. Purification, monoclonal antibody production, native and subunit molecular mass.Eur J Biochem 152: 21–28.
Clements PR, Brooks DA, McCourt PAG, Hopwood JJ (1989) Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies.Biochem J 259: 199–208.
Conzelmann E, Sandhoff K (1983/1984) Partial enzyme deficiencies: Residual activities and the development of neurological disorders.Dev Neurosci 6: 58–71.
Daniele A, Di Natale P (1987) Hunter syndrome: presence of material cross-reacting with antibodies against iduronate sulfatase.Hum Genet 75: 234–238.
Gasa S, Balbaa M, Nakamura M, Yonemori H, Makita A (1987) Phosphorylation of human lysosomal arylsulfatase B by cAMP-dependent protein kinase. Different sites of phosphorylation between normal and cancer tissues.J Biol Chem 262: 1230–1238.
Gautron S, Poenaru L, Boue J, Puissant H, Lisman JJW, Dreyfus J-C (1983) Evidence for the presence of β-subunit of hexosaminidase in a case of Sandhoff disease using a blotting technique.Hum Genet 63: 189–191.
Gibson GJ, Saccone GTP, Brooks DA, Clements PR, Hopwood JJ (1987) HumanN-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunitM r values.Biochem J 248: 755–764.
Ginns EG (1989) Application of immunoblotting to the study of the molecular genetics of inherited metabolic disorders. In Bjerrum OJ, Heegaard NHH eds.CRC Handbook of Immunoblotting of Proteins, vol. II. Boca Raton: CRC Press, 189–198.
Glossl J, Lembeck K, Gamse G, Kresse H (1980) Morquio's disease type A: absence of material cross reacting with antibodies againstN-acetylgalactosamine-6-sulfate.Hum Genet 54: 87–91.
Hasilik A, Neufeld EF (1980) Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.J Biol Chem 255: 4937–4945.
Himeno M, Koutoku H, Ishikawa T, Kato K (1989) Acid phosphatase in rat liver lysosomal membranes: purification and characterization.J Biochem 105: 449–456.
Hopwood JJ, Harrison JR (1982) High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharides.Anal Biochem 119: 120–127.
Hopwood JJ, Morris CP (1990) The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment.Mol Biol Med 7: 381–404.
Hopwood JJ, Muller V (1979) Biochemical discrimination of Hurler and Scheie syndromes.Clin Sci 57: 265–272.
Ishikawa E (1987) Development and clinical application of sensitive enzyme immunoassay for macromolecular antigens — a review.Clin Biochem 20: 375–385.
Jin W-D, Jackson CE, Desnick RJ, Schuchman EH (1992) Mucopolysaccharidosis type VI: Identification of three mutations in the arylsulphatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity.Am J Hum Genet 50: 795–800.
McKusick VA, Neufeld EF (1983) The mucopolysaccharide storage diseases. In Stanbury JB, Wyngaarden JB, Frederickson DS, Goldstein JL, Brown MS eds.The Metabolic Basis of Inherited Disease, 5th edn. New York: McGraw-Hill, 751–777.
Myerowitz R, Neufeld EF (1981) Maturation of α-l-iduronidase in cultured human fibroblasts.J Biol Chem 256: 3044–3048.
Myerowitz R, Robbins AR, Proia RL, Sahagian GG, Puchalski CM, Neufeld EF (1983) Studies of lysosomal enzyme biosynthesis in cultured cells.Methods Enzymol 96: 729–736.
Neufeld EF (1980) The uptake of enzymes into lysosomes: an overview.Birth Defects 16: 77–84.
Neufeld EF, Muenzer J (1989) The mucopolysaccharidoses. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill, 1565–1587.
Parenti G, Willemsen R, Hoogeveen AT, Verleun-Mooyman M, Van Dongen JM, Galjaard H (1987) Immunocytochemical localization of lysosomal acid phosphatase in normal and ‘I-cell’ fibroblasts.Eur J Cell Biol 43: 121–127.
Parkhouse RM (1984) Immunopurification.Br Med Bull 40: 297–301.
Peters C, Braun M, Weber B et al (1990) Targeting of a lysosomal membrane protein: a tyrosine containing endocytosis signal in the cytoplasmic tail of lysosomal acid phosphatase is necessary and sufficient for targeting to lysosomes.EMBO J:9: 3497–3506
Roden L (1980) Structure and metabolism of connective tissue proteoglycans. In Lennarz WJ, ed.The Biochemistry of Glycoproteins and Proteoglycans. New York: Plenum Press, 267–371.
Rohrborn W, von Figura K (1978) Human placenta α-N-acetylglucosaminidase: Purification, characterization and demonstration of multiple recognition forms.Hoppe-Seyler's Z Physiol Chem 359: 1353–1362.
Rome LH, Garvin AJ, Neufeld EF (1978) Human kidney α-l-iduronidase: Purification and characterisation.Arch Biochem Biophys 189: 344–353.
Rose JK, Doms RW (1988) Regulation of protein export from the endoplasmic reticulum.Annu Rev Cell Biol 4: 257–288.
Schuchman EH, Desnick RJ (1988) Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual α-l-iduronidase activities.J Clin Invest 81: 98–105.
Schuchman EH, Guzman NA, Desnick RJ ((1984) Human α-l-iduronidase. I. Purification and properties of the high uptake (higher molecular weight) and the low uptake (processed) forms.J Biol Chem 259: 3132–3140.
Scott HS, Ashton LJ, Eyre HJ et al (1990) Chromosomal localization of the human α-l-iduronidase gene (IDUA) to 4p16.3.Am J Hum Genet 47: 802–807.
Scott HS, Litjens T, Nelson PV, Brooks DA, Hopwood JJ, Morris CP (1992) α-l-Iduronidase mutations (Q70X and P533R) associated with a severe Hurler phenotype.Hum Mutation 1: 333–339.
Shankaran R, Ameen M, Daniel WL, Davidson RG, Chang PL (1991) Characterization of arylsulfatase C isozymes from human liver and placenta.Biochim Biophys Acta 1078: 251–257.
Siciliano L, Fiumara A, Pavone L et al (1991) Sanfilippo syndrome type D in two adolescent sisters.J Med Genet 28: 402–405.
Steckel F, Hasilik A, von Figura K (1983) Biosynthesis and maturation of arylsulfatase B in normal and mutant cultured fibroblasts.J Biol Chem 258: 14322–14326.
Sukegawa K, Orii T (1985) Quantitation and biosynthesis of β-glucuronidase cross-reactive material in fibroblasts from patients with mucopolysaccharidosis VII.J Inher Metab Dis 8: 145–146.
Sukegawa K, Tomatsu S, Tamai Ket al (1992) Intermediate form of mucopolysaccharidosis type II (Hunter disease): A C1237 to T substitution in the iduronate sulphatase gene.Biochem Biophys Res Commun 183: 809–813.
Taylor JA, Gibson GJ, Brooks DA, Hopwood JJ (1990) HumanN-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts.Biochem J 268: 379–386.
Taylor JA, Gibson GJ, Brooks DA, Hopwood JJ (1991) α-l-Iduronidase in normal and mucopolysaccharidosis-type-I human skin fibroblasts.Biochem J 274: 263–268.
von Figura K, Hasilik A, Steckel F, van de Kamp J (1984) Biosynthesis and maturation of α-N-acetylglucosaminidase in normal and Sanfilippo B fibroblasts.Am J Hum Genet 36: 93–100.
Wicker G, Prill V, Brooks D et al (1991) Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.J Biol Chem 266: 21386–21391.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brooks, D.A. Review: The immunochemical analysis of enzyme from mucopolysaccharidoses patients. J Inherit Metab Dis 16, 3–15 (1993). https://doi.org/10.1007/BF00711309
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00711309